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Significance 
Maintaining an intricate balance between continued progenitor proliferation and cell cycle 
exit/differentiation is pivotal for proper brain development. Disruption of this delicate process 
can lead to brain malformations such as microlissencephaly. The current work identifies 
Dmrta2 as an important transcription factor that helps to regulate the fine tuning between cell 
cycle progression and neuronal differentiation. Mechanistically, this function of Dmrta2 
involves direct transcriptional regulation of a known repressor of neurogenesis Hes1. Our 
findings thus add Dmrta2 to the complex regulatory machinery controlling cortical NPC 
maintenance, and provide an explanation to the microlissencephaly caused by Dmrta2-
deficiency in model organisms and man. 
 
Abstract 
The mechanisms that determine whether a neural progenitor cell (NPC) re-enters the cell 
cycle or exits and differentiates are pivotal for generating cells in correct numbers and 
diverse types, and hence dictate proper brain development. Combining gain-of-function and 
loss-of-function approaches in an embryonic stem cell-derived cortical differentiation model, 
we report that Dmrta2 plays an important role in maintaining NPCs in the cell cycle. 
Temporally controlled expression of transgenic Dmrta2 in NPCs suppresses differentiation 
without affecting their neurogenic competence. In contrast, Dmrta2 knockout accelerates the 
cell cycle exit and differentiation into post-mitotic neurons of NPCs derived from embryonic 
stem cells and in Emx1-cre conditional mutant mice. Dmrta2 function was linked to the 
regulation of Hes1 and other proneural genes as demonstrated by genome wide RNAseq 
and direct binding of Dmrta2 to the Hes1 genomic locus. Moreover, transient Hes1 
expression rescues precocious neurogenesis in Dmrta2 knockout NPCs. Our study therefore 
establishes a novel link between Dmrta2 modulation of Hes1 expression and the 
maintenance of NPCs during cortical development. 
 
\body 
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Introduction 
Balancing neural progenitor cell (NPC) self-renewal and neuronal differentiation is essential 
for generating cells in correct numbers and diverse types during brain development (1, 2). As 
such, cortical neurogenesis is tightly regulated by a complex array of transcription factors 
that work in concert to coordinate NPC maintenance and differentiation. Proneural 
transcription factors, such as neurogenin (Neurog) and Neurod, act as the primary initiators 
of differentiation through their direct regulation of target genes associated with cytoskeletal 
reorganisation, migration and other critical differentiation processes (3, 4). Proneural 
transcription factors are themselves subject to transcriptional regulation by other cortical 
transcription factors such as Pax6 and Hes1. Pax6 acts upstream to promote neuronal 
differentiation through its direct activation of proneural genes (5). On the other hand, the 
basic helix-loop-helix transcription factor Hes1 promotes NPC proliferation and self-renewal 
through its repressive actions on proneural gene expression, thereby restricting spontaneous 
differentiation (6). Significant disruptions to this delicate regulatory network can result in 
severe developmental defects due to altered neuronal production (1, 2).  One such disorder 
is microlissencephaly, a rare genetic-linked group of neurodevelopmental malformations 
characterised by the absence of sulci and gyri of the cerebral cortex and an accompanying 
reduction in cortical size and volume. Recently, a loss-of-function mutation in the Doublesex- 
and Mab-3-related transcription factor A2 (DMRTA2, also known as DMRT5) gene has been 
reported in a case of microlissencephaly, implicating DMRTA2 as a critical regulator of 
cortical NPC dynamics (7). 
Dmrta2 belongs to the highly conserved family of Dmrt transcription factors whose roles in 
the developing reproductive system have been extensively characterised (8). However, a 
further site of expression and function of Dmrta2 has been found in the embryonic brain (9, 
10). Dmrta2 loss-of-function in Zebrafish leads to significant reductions in cortical size, 
coupled with reduced neuronal numbers (10, 11). Likewise, a smaller neocortex, particularly 
dorsomedial neocortex, has been observed in mice carrying null deletions of Dmrta2 (12-14). 
Together with the association of DMRTA2 mutation and microlissencephaly in humans, 
these findings implicate Dmrta2 as an important regulator for cortical neurogenesis. 
However, Dmrta2-null mice additionally present agenesis of the embryonic cortical hem. The 
cortical hem is the embryonic organizer for the hippocampus and a major regulator of 
cortical patterning outside the hippocampus. It provides a source of Wingless-related (WNT) 
and bone morphogenetic protein (BMP) signalling in the dorsomedial telencephalon to 
control proper cortical regionalisation and NPC expansion in a paracrine fashion (15, 16). 
Thus, the severe patterning and arealisation defects in Dmrta2-null model organisms prohibit 
a clear dissection between a direct role of Dmrta2 in NPC behaviour from the secondary 
effect of an overall reduction in extrinsic hem-derived signals. More recently, conditional 
Dmrta2 mutant mice (Dmrta2fl/fl;Emx1-cre), that delete Dmrta2 in cortical progenitors after 
cortical hem formation, also have reduced cortical hemisphere size suggesting a direct role 
of Dmrta2 in the control of NPC behaviour, which remains to be defined (14). 
Embryonic stem cells (ESCs) are capable of giving rise to all somatic cell types with easy 
access during in vitro differentiation. Mouse and human ESCs can efficiently generate 
cortical NPCs in culture without any added morphogens and subsequently differentiated into 
layer-specific neurons in a temporally regulated fashion recapitulating major steps of normal 
cortical development (17-19). In this study, we analysed the behaviour of mouse ESC-
derived cortical progenitors either lacking Dmrta2 or conditionally expressing transgenic 
Dmrta2 (9). We report that enforced expression of Dmrta2 in cortical NPCs suppresses 
neuronal differentiation without affecting neurogenic competence, while in its absence 
cortical NPCs undergo precocious cell cycle exit and neuronal differentiation in vitro and in 
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vivo. We provide evidence that Dmrta2 maintains NPC status via transcriptional regulation of 
Hes1. Thus, this study identifies a new layer of genetic control by Dmrta2 in fine tuning 
cortical NPC proliferation and terminal differentiation.  
Results 
Expression of Dmrta2 by ESC-derived cortical NPCs 
In order to achieve efficient induction of cortical fate from mouse ESCs, we incorporated in 
our protocol several measures previously shown to promote a dorsal telencephalic fate (Fig. 
1A) (17). These included dual SMAD inhibition with SB431542 and LDN193189 to 
accelerate neural induction (20), the addition of a Wnt inhibitor XAV to suppress 
caudalization (21, 22), and cyclopamine to antagonise ventralisation of neural progenitor 
cells by endogenous sonic hedgehog (SHH) signalling (cultures generated by this paradigm 
are referred to hereafter as cortical cultures) (18). As negative controls for cortical identity, 
we in parallel induced ESCs towards a ventral telencephalic fate with SHH, a caudal fate 
with retinoic acid, and a ventral mesencephalic (dopaminergic) fate using a combinatorial 
treatment of ERK inhibitor and SHH (Fig S1A) (23). The generation of cortical NPCs was 
verified by immunostaining at day 6-8 for cortical specific or cortical enriched markers Pax6, 
Lmx1a, Eomes (Tbr2), Otx2, Coup-TF1 and FORSE-1 (also known as LeX) along with nestin 
as a pan NPC marker (Fig. 1B and C, Fig. S1B and D). The vast majority of cells in the 
cortical cultures stained positive for Pax6, FORSE-1, Otx2, Lmx1a, Coup-TF1 and nestin, 
while a proportion of cells also expressed Eomes. The transcription factor Nkx2.1 is 
specifically expressed by medial ganglionic eminence progenitors. While abundant Nkx2.1+ 
cells were detected in SHH treated ventral telencephalic cultures, negligible numbers of 
Nkx2.1+ cells were found in cortical cultures (Fig. S1B). Foxa2 is a marker for the ventral 
midbrain and spinal cord. Few Foxa2+ cells were observed in the cortical cultures while they 
constituted the major population in dopaminergic differentiated cultures (Fig. S1C).  
Double immunocytochemistry showed that Dmrta2+ cells were confined to Nestin+ and 
FORSE-1+ NPCs in cortical cultures, representing 30-54% of the total cell population 
between day 4-10 (Fig. 1B and D). During development, Dmrta2 expression is restricted to 
the dorsal telencephalon where it is co-expressed with Pax6 but in an opposite gradient (12, 
13, 24). Consistent with its expression in vivo, we found that Dmrta2 and Pax6 staining 
largely overlapped in ESC-derived NPCs localized in neural rosettes, from which Eomes+ 
basal progenitor cells could be seen extending distally (Fig. 1C). In contrast, no Dmrta2+ 
cells were found in SHH- or retinoic acid- treated neural progenitor cultures (Fig S1B and D).  
Dmrta2+ cells were no longer detectable by day 15 of differentiation. At this stage, the 
presence of postmitotic cortical neurons was confirmed by immunostaining for cortical layer-
specific neuronal markers Tbr1 (layer VI), Bcl11b (Ctip2 (layer V and VI)), and Satb2 (layer 
II/III) and a pan-glutamatergic neuronal marker vGlut1 (Fig. 1E and F, Fig. S1E). Very few 
GABAergic neurons, identified by GAD65/67 immunostaining, were observed in the cortical 
cultures (Fig. S1E). Moreover, we did not observe TH+/Nurr1+ dopaminergic neurons or 
Isl1+/Olig2+ spinal motor neurons, confirming an enrichment of cortical neurons in our 
cultures (Fig S1F and G). Together, our data demonstrates the ability to reproduce in vitro 
Dmrta2+ dorsal telencephalic NPCs and their neuronal progeny. 
Enforced expression of Dmrta2 suppresses NPC neuronal differentiation 
To investigate a role for Dmrta2 in telencephalic NPC behaviour, we firstly examined the 
effect of Dmrta2 gain of function in neuronal differentiation of ESC-derived NPCs using a 
tetracycline-inducible Dmrta2 transgenic mESC model (Dmrta2-ESCs) reported previously 
(9). These cells harbour the reverse tetracycline-controlled transactivator (rtTA) and produce 
significant levels of Dmrta2 protein in response to the addition of doxycycline to the culture 
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media. Dmrta2 transgene was induced at the peak of NPC production for 7 days from day 5 
and the expression of several neurogenic genes examined by qPCR (Fig. 2A and B). In the 
control condition, without doxycycline, the level of proneural gene transcripts (Neurog2, 
Neurod1 and Neurod4) increased gradually from day 6, along with the immature neuronal 
marker gene Tubb3 (β3-tubulin). However, lower levels of all these transcripts were detected 
in parallel sister cultures treated with doxycycline at all timepoints analysed. In contrast, the 
transcript levels of Hes1, a repressor of cortical neurogenesis, was robustly upregulated 
(Fig. 2B). These gene expression changes were concurrent with the induced transgenic 
Dmrta2 from day 6, which remained at a higher level than in control cultures throughout. 
Consistent with the qPCR observations, cells exposed to doxycycline for 5 days maintained 
a largely NPC morphology while the sister control cells progressed to terminal differentiation 
into neurons (Fig. 2C). Immunostaining confirmed a marked reduction of Tubb3+ cells in 
doxycycline treated cultures compared to controls. In contrast, doxycycline-treated cultures 
contained more Nestin+ NPCs (Fig. 2D). Moreover, double immunocytochemistry for Dmrta2 
and Tubb3 revealed mutually exclusive staining in doxycycline-treated cultures, providing 
direct evidence that a high level of Dmrta2 suppresses neuronal differentiation of NPCs (Fig. 
2E).  
Interestingly, upon removal of doxycycline after 4 days treatment, the NPCs readily gave rise 
to Tubb3+ neurons (Fig. S2). This finding suggests that a high level of Dmrta2 favours NPC 
maintenance over neuronal differentiation without affecting their neurogenic competence.   
Loss of Dmrta2 accelerates neuronal differentiation of cortical NPCs 
To gain further insights into the physiological function of Dmrta2 in neurogenesis and the 
cellular mechanisms that might underpin microcephaly caused by Dmrta2 loss-of-function 
mutation, we generated lines of mESCs with homozygous deletion of Dmrta2 (Dmrta2-/-) by 
gene targeting and directed these cells towards cortical fate (Fig. 3 and Fig. S3). We closely 
monitored neural induction and neuronal differentiation in Dmrta2-/- and isogenic control 
(Dmrta2flox/flox) cultures by immunocytochemistry and qPCR (Fig. 3A and B). Rapid 
neuroepithelial fate conversion was observed in both genotypes as demonstrated by the 
generation of a similar proportion of Nestin+ NPCs at day 4 and day 6 (Fig. 3A). However, 
following the onset of Dmrta2 expression at day 4, we observed marked differences in the 
temporal expression profile of the intermediate progenitor marker gene Eomes, neuronal 
marker Map2, and proneural transcription factors Neurog2 and Neurod1 (Fig. 3B).  Map2 
and Eomes levels were increased in the Dmrta2-/- cultures while both Neurog2 and Neurod1 
RNA reached their highest levels sooner in Dmrta2-/- cells than the control cells, suggesting 
an early initiation of neurogenesis programme.  Consistent with this observation, we 
detected an increase in the production of Tubb3+ neurons in Dmrta2-/- cultures by 
immunostaining at days 4, 6 and 8 compared to the isogenic control cultures (Fig. 3C). 
Similarly, Dmrta2-/- cultures also contained significantly more NeuN+ cells (mature neurons) 
at days 10 to 14 (Fig. 3D).  
In the reduced cortex of Dmrta2-/- embryos, a transient increase in neuronal production has 
also been observed during early corticogenesis. This excess of neuronal production during 
early neurogenesis may be a secondary consequence of the reduction of Wnt cortical hem 
signals or a direct consequence of the loss of Dmrta2 in cortical progenitors (12). To test this 
latter possibility, we assessed by immunostaining the amount of Tubb3+ and Eomes+ cells in 
the cortical plate of E11 conditional Dmrta2 mutant mice (Dmrta2fl/fl;Emx1-cre) in which Wnt 
signalling pathway appears unaffected (14). An increase of Tubb3+ and of Eomes+ cells was 
found in the conditional Dmrta2 mutant mice relative to controls (Fig. 4). Thus, premature 
neuronal differentiation is also a feature in vivo of conditional Dmrta2 mutant mice, 
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corroborating the in vitro observations and suggesting a direct role for Dmrta2 in cortical 
NPC neurogenesis. 
Altered Dmrta2 levels leads to cell cycle dysregulation in cortical NPCs 
Disrupted cortical NPC proliferation and cell cycle progression has been implicated as an 
underlying mechanism for microlissencephaly (25). To determine whether Dmrta2 plays a 
role in cell cycle regulation, we performed a flow cytometry-based cell cycle analysis to 
reveal the distribution of Nestin+ NPCs in three major phases of the cell cycle (G0/1, S and 
G2/M) (Fig. 5A). Significantly more Dmrta2-/- cortical NPCs were found in G0/1 phase 
(p<0.01) than the control cells at day 6 of differentiation (Fig. 5B). Accordingly, the number of 
cells in the S phase was reduced (p<0.05) in day 6 Dmrta2-/- NPCs compared to controls, 
although no differences were found on days 8 and 10.  
To gain further insight into Dmrta2-regulated cell cycle progression, we carried out EdU 
incorporation assays at days 6, 8 and 10 of differentiation. This study revealed a reduction in 
the number of EdU-labelled cells in Dmrta2-/- cultures compared to control cultures at all 
three time points, providing independent evidence of altered S phase in Dmrta2-/- NPCs (Fig. 
5C).  Moreover, immunocytochemical analysis showed that cells expressing Cdkn1b 
(p27kip1) and Cdkn1c (p57Kip2) are both increased in Dmrta2-/- cultures compared to 
controls (Fig. 5C). Cdkn1b and Cdkn1c are cell cycle regulators with a major function to halt 
or slow the G1-S phase transition and hence their upregulation is closely associated with cell 
cycle exit and neuronal differentiation. In contrast, we observed a reduction at the transcript 
level of these two cell cycle regulators and an increase in the proportion of Ki67+ cells when 
NPCs were forced to express Dmrta2 (Fig. S4). Together, these findings identify a new role 
for Dmrta2 in NPC cell cycle regulation and suggest that the disrupted regulation of cell cycle 
progression in Dmrta2-/- NPCs may be a significant contributory factor to the precocious 
neurogenesis described above. 
Genome-wide transcriptome profiling supports a role for Dmrta2 in NPC neurogenesis 
In order to gain insight into the molecular mechanisms underlying the altered neurogenesis 
in Dmrta2-deficient NPCs, we carried out a transcriptome analysis by RNA sequencing 
(RNAseq) using day 8 cultures, a timepoint associated with the highest number of Dmrta2+ 
cells and when both neurogenic and proliferative defects were apparent. Analysis of this 
RNAseq dataset identified 7343 differentially expressed transcripts at a significance level of 
p<0.05 (Fig. 6A, Fig. S5 and Dataset S1). Amongst the Dmrta2-regulated genes were a 
number of transcription factors involved in cortical development and patterning, including 
Foxg1, Pax6, Emx1, Emx2, Nr2f1 (Coup-TF1) and Sp8 (Fig. 6B and C). Similarly, genes 
associated with development of the cortical hem, Lmx1a and Msx1, were significantly 
downregulated in Dmrta2-/- cultures. Interestingly, Dmrta2 itself was identified as one of the 
most significantly upregulated transcripts upon loss of Dmrta2 (Fig. 6B and Fig. S5C). The 
closely-related Dmrt family member Dmrta1 was also upregulated in Dmrta2-/- NPCs, while 
no significant change was found for Dmrt3. In the reduced cortex of Dmrta2 conditional 
mutants, Dmrta2 and Dmrta1 have been also found to be upregulated (14). Together, these 
observations further support a negative autoregulatory function for Dmrta2, as well as 
regulatory interactions with other Dmrt family members.  
We are particularly interested in genes and gene-sets that have a functional role in NPC 
proliferation and/or neuronal differentiation. Our data revealed a significant downregulation 
of Hes1 (Fig. 6C). Downregulated expression was also identified for other transcription 
factors known to complex with Hes1 to repress proneural gene expression and promote 
NPC proliferation, including Id1, Id3 and Tcf3 (6, 26, 27). In contrast, we found an 
upregulation in the expression of Hes1 target proneural genes Neurog1, Neurog2 and Ascl1, 
together with their downstream target genes Neurod1, Neurod4 and Nhlh1 (3, 4). 
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Furthermore, genes known to perform opposing actions to Hes1 by promoting the 
expression of proneural genes were upregulated, including Pax6 and Btg2 (5, 28). Other 
upregulated transcription factors with pro-neuronal functions included Insm1, Myt1l and Brn2 
(29, 30). Consistent with these findings, molecular markers for intermediate progenitor 
(Eomes), immature (Dcx) and mature (Mapt, Nefh and Rbfox3) neurons were also 
upregulated in Dmrta2-/- cells (Fig. 6D). 
To provide a broader overview of the cellular functions played by Dmrta2-regulated 
genes/gene-sets, we performed a gene ontology functional enrichment analysis using gene 
lists meeting the stringent criteria of p<0.01 and an absolute fold change value greater than 
two. This analysis revealed that the 650 upregulated genes meeting these criteria are 
enriched in transcripts associated with biological processes including neuronal 
differentiation, neurogenesis and nervous system development in general (Fig. S5A). 
Similarly, enrichments for genes linked to the regulation of cell proliferation, organ 
morphogenesis and locomotion were identified in 936 transcripts downregulated in Dmrta2-/- 
cortical NPCs (Fig. S5B). Together, our global gene expression analysis provides strong 
independent support that Dmrta2 plays a role in balancing NPC proliferation and 
neurogenesis. 
Dmrta2-controlled neuronal differentiation involves direct regulation of Hes1 
The significant downregulation of Hes1 revealed by the RNAseq analysis in addition to its 
robust induction in response to Dmrta2 transgene expression in NPCs suggests that Dmrta2 
may maintain cortical NPC status via regulating Hes1 transcription. To determine whether 
this is mediated by direct binding of Dmrta2, we performed chromatin immunoprecipitation 
(ChIP) on day 8 Dmrta2flox/flox NPCs, with Dmrta2-/- NPCs serving as a negative control. 
Based on the published consensus binding sequence for Dmrta2, we identified three 
potential binding sites (Bs1-3) at the Hes1 locus (Fig. 7A) (31). Dmrta2-immunoprecipitation 
of DNA fragments at each of these sites was quantified relative to a non-bound control 
region (NBCR) by qPCR (Fig. 7B). An enrichment in Dmrta2-bound fragments was identified 
at binding sites Bs1 and Bs2 (p<0.05) but not in Bs3 in Dmrta2flox/flox cells. In contrast, no 
enrichment was detected at any of the three potential binding sites in Dmrta2-/- negative 
control cells. Thus, Dmrta2 binds to the Hes1 gene in NPCs.  
To provide evidence for Dmrta2 regulatory activity at Bs1 and Bs2, we performed reporter 
assays using a Hes1 promoter-driven luciferase vector (32). A two-fold higher basal Hes1 
promoter activity level was recorded in the isogenic Dmrta2flox/flox cultures relative to the 
Dmrta2-/- NPCs on day 8 of differentiation (p<0.001) (Fig. 7C). An A>C point mutation at 
position -3 of the binding motif has been shown to significantly impair the ability of Dmrta2 to 
bind to its target sequence (31). We therefore introduced A>C point mutations at Bs1 and 
Bs2 by site-directed mutagenesis to yield two mutated reporter constructs, pHes1-luc-
Bs1g.2007A>C and pHes1-luc-Bs2g.2365A>C, respectively. The mutation at Bs1, but not 
Bs2, resulted in a significant reduction of elevated Hes1 promoter activity levels in 
Dmrta2flox/flox  NPCs relative to the parental luciferase construct (p<0.01), suggesting reduced 
binding of Dmrta2 to the mutated Bs1 (Fig. 7C). Together these data strongly support the 
ability of Dmrta2 to bind to and regulate transcriptional activity at Bs1 on the Hes1 genomic 
locus. 
We next sought to determine the extent to which reduced Hes1 expression in Dmrta2-/- 
NPCs may contribute to their altered neurogenesis. To this end, Dmrta2flox/flox and Dmrta2-/- 
NPCs were transfected with a Hes1-expression vector on day 6 of differentiation together 
with a GFP-coding plasmid to distinguish between Hes1-transfected and non-transfected 
cells (Fig. 7D). By quantifying Tubb3 staining 48 hours post-transfection, we identified 
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significantly increased numbers of neurons in the non-transfected population of Dmrta2-/- 
cells relative to non-transfected isogenic controls (p<0.01). As predicted based on known 
Hes1 function, Hes1 transgene expression led to a reduction in neuronal production for each 
cell line. Interestingly, no significant differences between cell lines were identified within the 
Hes1 transfected populations. Thus, Hes1 trangene expression leads to a rescue of the 
precocious neurogenesis associated with the loss of Dmrta2.  
We then asked whether siRNA-mediated knockdown of Hes1 expression could attenuate the 
anti-neurogenic effect of Dmrta2 transgenic expression in cortical NPCs. Dmrta2-ESCs were 
treated with doxycycline and Hes1-siRNA or a control non-targeting siRNA from day 5 to 12 
of differentiation. Hes1-knockdown resulted in a significant reduction of Nestin+ NPCs 
(p<0.05) and concurrent increase in the proportion of Tubb3+ neuronal cells (Fig. 7E). Thus, 
Hes1 knockdown partially reverses Dmrta2-mediated suppression of neuronal differentiation.  
Together, our data identify Hes1 as a downstream target of Dmrta2 transcriptional regulation 
and a mechanism through which Dmrta2 safeguards NPCs from premature differentiation. 
Discussion 
Dmrta2 in NPC cell cycle regulation 
Loss-of-function mutations in Dmrta2 have been linked with microcephaly in zebrafish, mice 
and humans (7, 10-13). However, the role and mechanism of action of Dmrta2 in the control 
of NPC maintenance and expansion remains, until now, completely unknown. Recently, 
conditional Dmrta2 mutant mice (Dmrta2fl/fl;Emx1-cre) have been created that delete Dmrta2 
in cortical progenitors after cortical hem formation without impacting Wnt signalling. The 
Dmrta2 cKO embryos also show reduced cortical hemisphere size suggesting a direct role of 
Dmrta2 in the control of NPC behaviour (14). Cells in a monolayer ESC-neural differentiation 
system are by and large exposed to the same extracellular environment and don’t form 
‘signalling centres’ as those found in the developing brain. Moreover, daily changes of 
culture media will reduce the impact of any secreted molecules that may elicit a secondary 
effect. Our pathway analysis of the RNAseq data did not reveal any significant changes in 
Wnt signalling, therefore, the observed effect of Dmrta2 on cell cycle changes is likely cell 
autonomous.   
In line with the accumulation of Dmrta2-/- NPCs in the G0/G1 phase of the cell cycle, our 
study reported the altered expression of a number of cell cycle regulatory genes, particularly 
those acting on the G1 to S phase transition (Cdkn1b, Cdkn1c and Btg2). Together, these 
data suggest a disruption in cell cycle progression and potential lengthening of the G1 phase 
in Dmrta2-/- NPCs. During normal corticogenesis the duration of the G1 phase is linked to 
neuronal differentiation and is always higher in cells committed to undergo differentiative 
rather than proliferative divisions (33, 34). Furthermore, experimental lengthening of the G1 
phase pharmacologically or by the induction of Cdkn1b or Cdkn1c expression promotes 
neuronal differentiation and depletion of the NPC pool resulting in microcephaly (1, 33, 35). 
The observed increase of Cdkn1b and Cdkn1c in Dmrta2-/- NPCs strongly implicates delayed 
cell cycle progression of Dmrta2-/- NPCs as a cellular mechanism contributing to precocious 
neurogenesis. However, it is unclear at present whether this is achieved through the direct 
regulation of cell cycle progression genes by Dmrta2. Although a number of G1-S transition 
regulatory molecules are known to act as downstream targets for Hes1 repression, Cdkn2c 
(p18ink4c) has also been identified as a candidate gene for direct Dmrta2-mediated 
regulation in the zebrafish testes (11, 36, 37). Whether or not through a direct effect, our 
study demonstrates that Dmrta2 is intricately linked with the control of cell cycle progression, 
a feature conserved across species and tissues. 
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In addition to their function in the regulation of cell cycle progression, cyclin-dependent 
kinase inhibitors, including Cdkn1b, directly influence and promote NPC differentiation by 
stabilising protein levels of Neurog2 via direct binding and the regulation of both interkinetic 
and radial migration (35, 38, 39). The transcriptome analysis of Dmrta2-/- NPCs identified an 
enrichment of downregulated transcripts associated with gene ontology terms for cell 
adhesion (GO:0007155) and locomotion (GO:004001). It is therefore possible that defective 
migration is a cellular phenotype associated with the loss of Dmrta2 that could potentially 
lead to increased neuronal differentiation. Similarly, our RNAseq data alludes to a potential 
switch in the mode of cell division of Dmrta2-/- NPCs. The transcription factors Emx2 and 
Pax6 were found to be downregulated and upregulated, respectively, by Dmrta2-/- NPCs, as 
well as in the brains of Dmrta2-null mice (12). Further to their roles in telencephalic 
patterning, Emx2 is known to promote symmetric proliferative division of NPCs and Pax6 
asymmetric differentiative division (40, 41). Thus, a switch in the mode of proliferation to 
neurogenic divisions may be a further cellular feature contributing to increased differentiation 
in the absence of Dmrta2. This is supported by the strong upregulation of mRNA transcripts 
for Btg2 which is exclusively expressed in cortical NPCs committed to undergoing 
neurogenic but not proliferative divisions (42). Thus, while we provide evidence that Dmrta2 
safeguards NPCs from precocious neurogenesis via regulation of Hes1, other targets may 
also contribute to the fine control of neurogenesis by Dmrta2.  
Dmrta2 targets and neurogenesis 
To date, Hes1 and Cdkn2c are the only two transcriptional targets proposed for Dmrta2. Due 
to high levels of conservation in DNA binding motifs between Dmrt proteins, further insight 
may be provided by examining DNA binding sites of related Dmrt family members in other 
tissues (31). Close to 1,400 direct binding sites for Dmrt1 in the mouse testis have been 
identified using ChIP-chip techniques (43). Many of these genes were also identified as 
dysregulated by our Dmrta2-/- NPC transcriptome analysis, including: Cdkn2c, Igf2r, Meis1, 
Hox family members and other Dmrt genes. Although Dmrt1 is not expressed by cortical 
NPCs, our data suggests significant overlaps in the regulatory targets of different Dmrt 
proteins. This is of particular interest due to the similar expression patterns of Dmrt3, Dmrta1 
and Dmrta2 in the dorsal telencephalon suggesting a potential for functional redundancy (13, 
24). A similar but less severe phenotype to that seen in Dmrta2 null mutants has been 
observed in mice with a Dmrt3 null mutation, further supporting the idea that the two factors 
have overlapping function in cortical development (12-14). In contrast, Dmrta1-null mice 
produce viable offspring with no overt anatomical defects in the brain (13, 44). This implies a 
hierarchical structure of importance of the Dmrt proteins to cortical development. Similar to 
our transgenic Dmrta2 findings, forced expression of Dmrt3 or Dmrta1 in the rodent 
telencephalon is linked to the regulation of Neurog2 expression (24). Further studies may 
reveal to what extent this functional overlap exists between Dmrt family members in the 
dorsal telencephalon. 
The functions of the Notch target gene Hes1 in maintaining NPC self-renewal have been 
well characterised (6). Notch ligands produced by newborn neurons activate notch signalling 
in neighbouring cells which in turn induces expression of Hes1 to repress the transcription of 
proneural factors and cell cycle progression regulators, thereby inhibiting neuronal 
differentiation (6, 36, 37). This lateral inhibition of spontaneous neuronal differentiation by 
neighbouring cells favours NPC proliferation and self-renewal. However, Hes1 expression is 
dynamically regulated by a number of mechanisms including: a strong negative 
autoregulatory function, which is in turn inhibited by interactions with Id proteins (45, 46); the 
activity of other transcription factors, such as Lhx2 (47); and the activation of signalling 
pathways by growth factors and mitogens including Fgf2 and Notch (6, 48). Under healthy 
conditions, these homeostatic mechanisms help maintain a NPC pool through development 
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by regulating the expression of Hes1 and, therefore, the balance between progenitor cell 
self-renewal and differentiation. This study identifies Dmrta2 as a novel factor contributing to 
the dynamic regulation of Hes1 expression in cortical NPCs. By promoting Hes1, and 
thereby suppressing downstream proneural gene expression, Dmrta2 helps contribute to the 
maintenance of NPC self-renewal (Fig. 8A). In the absence of Dmrta2, Hes1 levels are 
reduced, leading to the upregulation of proneural genes and increased neuronal 
differentiation (Fig. 8B).  
In summary, we have identified Dmrta2 as a modulator controlling neuronal differentiation of 
cortical NPCs and provided evidence that Dmrta2 exerts this function, at least in part, by 
direct transcriptional regulation of neurogenesis inhibitor Hes1. Thus, this work points to 
another layer of control mechanisms coordinating NPC maintenance and neurogenesis, and 
begin to elucidate how Dmrta2 loss-of-function mutations may lead to microcephaly.  
Materials and Methods 
Cell culture 
Six mouse ESC lines were used: a Dmrta2flox/flox control line and two Dmrta2-/- lines derived 
from the control line line (SI Materials and Methods), two independent doxycycline inducible 
Dmrta2 overexpression ESC lines and their parental lines harbouring rtTA as reported 
previously (9). All ESCs were maintained under standard conditions as previously described 
(17).  For monolayer based cortical differentiation, ESCs were seeded at 10 000 cells/cm2 in 
gelatin-coated 6 well plates and cultured in N2B27 medium. Differentiation medium was 
supplemented with 100 nM LDN193189, 10 µM SB431542 from days 0 to 4, 1 µM XAV939 
from day 0 to 6 (all Tocris) and 1 µM cyclopamine between days 2 and 10 (Sigma-Aldrich). 
On day 5 or 6 of differentiation, neural progenitor cells were dissociated using Trypsin/EDTA 
and replated onto poly-D-lysine/laminin coated surface at a density of 50,000 cells/cm2 for 
neuronal differentiation and maturation.  
Transient transfections were performed using lipofectamine 3000 reagent (Thermofisher 
Scientific). The following vectors were used: pHes1(2.5k)-luc (Addgene) (32); 
pGL4.73[hRluc/SV40] (Promega); pCAG-Hes1-IP and pmaxGFP (Lonza). Accell Hes1 and 
non-targeting control siRNA (GE Dharmacon) were used at a concentration of 1 µM. 
Mouse Lines 
Emx1-cre and Dmrta2fl/fl mouse lines were generated and maintained as previously 
described (14). 
Quantitative RT-PCR (qPCR) 
Total RNA was extracted using Tri reagent treated with TURBO DNase. cDNA was 
generated using qScript cDNA synthesis kit. qPCR was performed with Mesa Green qPCR 
master mix with specific primers listed in Table S1 and dissociation curves were recorded to 
check for amplification specificity. Cq values were normalised to a minimum of two 
housekeeping reference genes and changes in expression calculated using the 2-∆∆CT 
method (49). Three independent experiments were performed (n=3) and each sample 
measured in duplicate on a CFX Connect Real Time PCR machine. 
Immunocytochemistry and EdU-labelling 
Cultures were fixed with 4% (w/v) paraformaldehyde and permeabilised with 0.1% (v/v) 
Triton X-100. Following blocking with 2% (w/v) bovine serum albumin and 5% (v/v) donkey 
serum, cells were incubated with primary antibodies overnight at 4°C before incubated with 
complementary Alexa Fluor-conjugated antibodies and counterstained with DAPI. All 
antibodies used are listed in SI Materials and Methods. To quantify proliferation, 
differentiating cultures were incubated with 5 µM EdU for 30 minutes before fixation. EdU 
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detection was then carried out using the Click-iT EdU Alexa Fluor 488 imaging kit (Life 
Technologies, UK). Images were subsequently acquired using a DMI600b inverted 
microscope (Leica Microsystems). Manual cell counts were performed on a minimum of 10 
randomly placed fields of view per stain and the mean of three separate differentiations 
calculated (n=3).  
Embryo sections (6-8 µm) fixed overnight in 4% paraformaldehyde/PBS, dehydrated and 
paraffin-embedded were processed as described previously (14). For  quantification of cells 
expressing Tubb3, cells of the entire dorsal telencephalon at the medial level were counted 
(at least 2 embryos of each genotype were analysed with a quantification of 3 to 6 
sections/embryo). 
Cell cycle analysis by flow cytometry 
NPCs were dissociated with EDTA, washed in PBS and fixed with ice-cold 70% ethanol. 
After washing with 1% BSA, cell samples were incubated with mouse anti-Nestin (BD 
Biosciences, 611659, 1 µg/ml) or mouse IgG isotype (Sigma-Aldrich, I5381, µg/ml) 
antibodies overnight at 4°C. Following incubation with donkey anti-mouse Alexa-Flour 647 
secondary antibody (Thermofisher Scientific, A-31571, 1:1000), DNA content was labelled 
by incubating cells with 1 µg/ml DAPI. Stained cells were analysed on an Amnis Flowsight 
(Merck Millipore) under excitation from 405 nm and 642 nm lasers. IgG isotype control 
samples were used to set gating parameters for nestin+ neural progenitor cells and DAPI 
staining to identify cells at different stages of the cell cycle. Samples from three individual 
differentiation experiments were analysed for each time point (n=3). 
RNAseq 
RNA was extracted and purified using the PureLink RNA Mini Kit (Thermofisher Scientific). 
TruSeq Stranded mRNA kit (Illumina) was used to prepare libraries from 1 µg RNA from 3 
independent differentiations (n=3). 75bp paired-end sequencing was performed on a HiSeq 
4000 (Illumina, USA) yielding 30 – 45 million reads per sample. Reads were mapped to the 
mouse genome (mm10, GRCm38) using Burrows-Wheeler Aligner algorithms (50) and 
individual gene read counts calculated using featureCounts (51). DeSeq2 was used to 
calculate differential gene expression (52). Gene Ontology functional enrichment for 
biological processes was performed using DAVID (v6.8) with mus musculus genome set as 
background (53). Calculated p values were adjusted for multiple testing using the Benjamini-
Hochberg correction. Raw sequence data files are publically available from the NCBI Gene 
Expression Omnibus (GEO accession: GSE90827). 
Luciferase reporter assays 
Point mutations were introduced into the pHes1(2.5k)-luc firefly luciferase vector using a 
Quikchange II XL Site-Directed Mutagenesis kit (Agilent Technologies) and the mutagenic 
primers (5’3'): CAAGGTAAAGAGGATGTGTTCCTCTAATGTCTTCCGGAATT and 
AATTCCGGAAGACATTAGAGGAACACATCCTCTTTACCTTG for Bs1; and 
GAAAGTTCCTGTGGGAAAGAAAGTTTGGGAAGTTTCAC and 
CAAACTTTCTTTCCCACAGGAACTTTCAGCCAATGG for Bs2. Generation of mutagenized 
plasmids were confirmed by sanger sequencing. 
For luciferase reporter assays, cells were cultured in 24-well plates and co-transfected with 
290 ng/well firefly luciferase (pHes1(2.5k)-luc and it’s derivatives). 10 ng/well of renilla 
luciferase vector (pGL4.73) was used as an internal control to normalise for transfection 
efficiency and 50 ng of notch intracellular domain (NICD (pCAG-NotchIC-IP) served as a 
positive control. Cells were harvested 24 hours post-transfection and processed using the 
Dual-Glo Luciferase Assay System (Promega). Luciferase activity was measured with 
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GloMax 96 Microplate Luminometer (Promega). Triplicate readings were taken for each 
sample and all experiments repeated with three biological replicates (n=3). 
Chromatin immunoprecipitation (ChIP) 
Approximately 107 cells on day 8 of differentiation were used per immunoprecipitation. 
Protein and DNA were cross-linked with 1% formaldehyde before cell lysis. The extracted 
chromatin was subsequently sonicated at high power for 20 cycles of 30 seconds on/30 
seconds off with a Bioruptor (Diagenode). Immunoprecipitation was performed by incubating 
chromatin with custom rabbit anti-Dmrta2 or rabbit IgG isotype control antibodies and 
Salmon Sperm DNA/Protein A Agarose Beads (Merck Millipore). Following denaturation of 
crosslinks, Dmrta2-bound DNA fragments were purified using the Wizard SV Gel and PCR 
Clean-Up System (Promega). Immunoprecipitated DNA was subsequently amplified in 
qPCR reactions using the primers specified in Supplementary table 1. Two 
immunoprecipitations, each from a separate differentiation experiment, were performed (n = 
2). 
Statistical Analysis 
Statistical analyses were performed using IBM SPSS 20 software. Where specified, two way 
ANOVA tests were performed using Dmrta2 genotype status and day of differentiation as 
independent variables. Simple effects analysis by post-hoc Sidak’s test was used to correct 
for separate orthogonal comparisons between groups at each time point and to identify 
statistical significance. For luciferase assays and siRNA knockdown experiments one way 
ANOVA with Tukey-HSD post-hoc tests were performed. One tailed and two-tailed Student’s 
t-tests were used to analyse ChIP-qPCR and Hes1-transfection rescue experiments, 
respectively. 
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Figure legends 
Fig. 1. Dmrta2 expression in ESC-derived cortical NPCs. (A) Schematic representation of 
ESC cortical differentiation protocol. (B) Dmrta2 immunostaining on day 6 of differentiation 
showing co-labelling with other cortical markers. (C) Co-localised immunostaining of Dmrta2 
and Pax6 in neural rosettes on day 8 of differentiation, with Eomes+ basal progenitor 
extending distally (D) Quantification of the proportion of Dmrta2+ cells between days 4 and 
10 of differentiation. Data are presented as mean + s.e.m. of three independent 
experiments. (E) Immunocytochemistry for deep (Bcl11b (Ctip2) and Tbr1) and superficial 
(Satb2) layer cortical neuronal markers at day 15. (F) High magnification images of vGlut1 
and Bcl11b staining in dorsal telencephalic neurons. Scale bars: 100 µm. 
Fig. 2. Enforced expression of Dmrta2 in NPCs suppresses neuronal differentiation. 
(A) Experimental scheme.  Monolayer cultures of Dmrta2-ESCs were exposed to 
doxycycline or vehicle control from day 5 to 12. Cultures were harvested every day from day 
6 till 12 and samples processed for qPCR. (B) qPCR analysis of the genes indicated from 
day 6-12. Levels of mRNA expression were normalised to day 5. Error bars indicate means 
± s.e.m. of three biological replicates. (C) phase contrast view of day 10 cultures treated with 
doxycycline (bottom) or vehicle (top) from day 5. (D) sister cultures as C double stained with 
antibodies against Nestin (green) and Tubb3 (red). (E) day 10 cultures as C double stained 
for Tubb3 (green) and Dmrta2 (red). Scale bar: 100 µm. 
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Fig. 3. Loss of Dmrta2 in cortical NPCs accelerate neurogenesis in vitro. (A) Day 4 and 
day 6 cultures were immunostained for Nestin, revealing comparable generation of NPCs in 
the control and Dmrta2-/- cultures. (B) qPCR analysis of neuronal differentiation markers. 
Data are representative of 3 independent differentiation experiments. (C) Immunostaining 
and quantification of cells expressing an immature neuronal marker, Tubb3. Two way 
ANOVA identified a significant increase in the overall production of Tubb3+ neurons by 
Dmrta2-/- NPCs (F[1,16]=8.005, p=0.012).  (D) Immunostaining and quantification of cells 
expressing mature neuronal marker NeuN. Two way ANOVA revealed a significant increase 
in the overall maturation of neurons derived from Dmrta2-/- NPCs (F[1,16]=11.991, p=0.003). 
Scale bars: 100 µm 
Fig. 4. Loss of Dmrta2 in cortical NPCs accelerate neurogenesis in vivo. 
Immunostaining of Tubb3 and Eomes, left and right panel respectively, on coronal brain 
sections of E11 embryos. Note the increase of Tubb3+ and Tbr2+ cells (arrows in right 
panels) in the Dmrta2fl/fl;Emx1-Cre mutants compared to the controls. The graph is a 
representation of the number of Tubb3+ cells in Dmrta2fl/fl;Emx1-Cre and control embryos. 
Data are presented as mean ± s.e.m. of three independent experiments; *p<0.05, two-tailed 
Student’s t-test. Scale bar: 100 µm. 
Fig. 5. Disruption of cell cycle progression in Dmrta2-/- NPCs. (A) Cell cycle analysis of 
Dmrta2flox/flox and Dmrta2-/- NPCs by flow cytometry. NPCs were firstly immunostained with 
antibodies against Nestin (top), and DNA content measured by DAPI-labelling (bottom). (B) 
Quantification of cell distribution in G0/1, S and G2/M phases of the cell cycle. Data are 
presented as mean ± s.e.m. of three independent experiments; *p<0.05, **p<0.01; two-way 
ANOVA (F[1,12]=7.109, p=0.021) followed by Sidak’s post hoc test. (C) Quantification of 
EdU uptake, and the number of cells expressing cdkn1b (p27kip1) and cdkn1c (p57kip2). 
Two way ANOVA identified overall reduced proliferation in Dmrta2-/- NPCs, as indicated by 
EdU uptake (F[1,12]=11.336, p=0.006),  and an increase in the proportion of cells staining 
positive for Cdkn1b (F[1,12]=20.804, p<0.001) and Cdk1nc (F[1,12]=10.477, p=0.007). Data 
are presented as mean ± s.e.m. of three independent experiments. Scale bar: 100 µm. 
Fig. 6 Genome wide transcriptome analysis supports a role for Dmrta2 in 
neurogenesis. (A) Heatmap depicting 7343 differentially expressed mRNA transcripts 
(p<0.05) identified by RNAseq. (B-D) Examples of differentially expressed genes associated 
with telencephalic patterning and development (B), transcription factors known to regulate 
neuronal differentiation (C), and markers of different stages of neuronal maturation (D). 
Fig. 7. Hes1 is a direct target for Dmrta2 transcriptional regulation in NPCs. (A) 
Schematic representation of the Hes1 genomic locus showing the relative positions of 
predicted Dmrta2 binding sites (Bs1 – Bs3) and non-binding control region (NCBR), and the 
primer pairs used to amplify each region following ChIP. (B) ChIP-qPCR for each of the 
regions depicted in (B) using chromatin prepared from Dmrta2flox/flox and Dmrta2-/- NPCs on 
day 8 of differentiation. Data are presented as mean fold enrichment relative to the NBCR ± 
s.e.m. of three immunoprecipitations, each prepared from an independent differentiation 
experiment; *p<0.05; one-tailed Student’s t-test. (C) Reporter assay performed in 
Dmrta2flox/flox and Dmrta2-/- NPCs on day 8 of differentiation using wildtype or mutant Hes1 
promoter-luciferase vectors carrying a point mutation at Bs1 or Bs2, respectively. Data are 
presented as mean ± s.e.m. of three independent transfections with reporter plasmids; 
**p<0.01; one way ANOVA with Tukey-HSD post-hoc test. (D) Dmrta2flox/flox and Dmrta2-/- 
NPCs were co-transfected with GFP- and Hes1-expression vectors on day 6 of 
differentiation. Cultures were immunostained for Tubb3 48 hours later. Successfully 
transfected cells overexpressing Hes1 were identified based on GFP-expression. Data are 
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presented as mean ± s.e.m. of three transfections, each from an independent differentiation 
experiment; *p<0.05; two-tailed Student’s t-test. (E) Monolayer cultures of Dmrta2-ESCs 
were exposed to doxycycline with or without non-targeting control or Hes1 siRNA from day 
5. The proportion of Nestin+ NPCs and Tubb3+ neurons was quantified at day 12. Data are 
presented as mean ± s.e.m of >20 individual fields of view; **p<0.05; one way ANOVA with 
Tukey-HSD post-hoc test. 
Fig. 8. Dmrta2 modulates neurogenesis through regulation of Hes1. Schematic model 
depicting the function of Dmrta2 in the modulation of NPC maintenance and neuronal 
differentiation. (A) High Dmrta2 expression in cortical NPCs ensures high expression of 
Hes1 and low levels of proneural genes, thus promoting NPC maintenance and cortical 
expansion.  (B) Upon differentiation, Dmrta2 expression declines resulting in reduced levels 
of Hes1 and higher expression of proneural gene, thus enhancing the differentiation of NPCs 
into post-mitotic neurons. 
 
 
 
 








SI Appendix 
The Doublesex-related Dmrta2 safeguards neural progenitor maintenance 
involving  transcriptional regulation of Hes1
Author affilations 
Fraser I. Young1, Marc Keruzore2#, Xinsheng Nan3,#, Nicole Gennet1, Eric J. Bellefroid2‡, 
Meng Li1,3‡
1, Neuroscience and Mental Health Research Institute, School of Medicine, Cardiff 
University, Cardiff, CF24 4HQ, UK 
2, Laboratoire de Génétique du Développement, Institut de Biologie et de 
MédecineMoléculaires, Université Libre de Bruxelles, Rue des Profs Jeener et Brachet, 
126041 Gosselies, Belgium
3, School of Bioscience, Cardiff University, Cardiff, CF24 4HQ, UK 
‡Corresponding authors: Meng Li, email: LiM26@cardiff.ac.uk Tel: +44-29-
20688345; Eric Bellefroid, email: ebellefr@ulb.ac.be Tel: +32 26509732 
SI Materials and Methods 
Generation of Dmrta2-/- and Dmrta2flox/flox mESCs 
The Dmrta2 gene was targeted by homologous recombination using a Dmrta2 targeting 
construct containing 5’ and 3’ arms for homologous recombination, a CMVhygrotkpA 
cassette flanked by two FRT sites for selection and subsequent removal of the selection 
cassette by flippase (Flp), exon 2 (E2) flanked by two loxP sites for Cre-mediated conditional 
knockout, and a Lox2272 site for facilitating exchange of reporters to the Dmrta2 locus (Fig 
S3A). Targeting was screened by southern blots for homologous recombination (Fig. S3B). 
In order to target the second Dmrta2 allele, the CMVhygrotkpA cassette was removed from 
the first targeted Dmrta2mut allele by transfection with Flp construct to result in Dmrta2flox. The 
Dmrta2flox allele was distinguished from wildtype Dmrta2 by PCR genotyping using forward 
primer Dmrta2-KO7-p3f and reverse primer Dmrta2-KO7-p1r (Fig. S3C and Table S1). After 
targeting of the second Dmrta2 allele, Dmrta2flox/mut mESCs were transfected with Flp 
construct to remove CMVhygrotkpA cassette from the second allele to generate control 
Dmrta2flox/flox mESCs. To generate Dmrta2 null ES cells (Dmrta2-/-), Dmrta2flox/mut cells were 
co-transfected with both Flp and Cre constructs to simultaneously remove CMVhygrotkpA 
cassette. 
ESC differentiation
To differentiate ESCs towards a ventral telencephalic fate cells were seeded at 10 000 
cells/cm2 in gelatin-coated 6 well plates and cultured in N2B27 medium. Differentiation 
medium was supplemented with 100 nM LDN193189, 10 µM SB431542 from days 0 to 4, 1 
µM XAV939 from day 0 to 6, and 1 µg/ml SHH and 10nM SAG (all Tocris) between days 2 
and 10 (Sigma-Aldrich). To obtain a more caudal phenotype ESCs were seeded at 10 000 
cells/cm2 in gelatin-coated 6 well plates and cultured in N2B27 supplemented with 100 nM 
LDN193189 and 10 µM SB431542 from days 0 to 4. Between days 2 and 6 of differentiation 
N2B27 prepared with B27 supplement containing vitamin A was used. ESCs were 
differentiated towards a ventral midbrain fate as described previously (23). Briefly, ESCs 
were seeded at 2 500 cells/cm2 in gelatin-coated 6 well plates and cultured in N2B27 
medium. Differentiation medium was supplemented with PD0325901 from day 2 to 4 and 
100 ng/ml SHH, 1 µM Purmorphamine (all Tocris) and 100 ng/ml Fgf-8 between days 7 and 
11. On day 5 of differentiation neural progenitor cells were dissociated using Trypsin/EDTA 
and replated onto poly-D-lysine/laminin coated surface at a density of 50,000 cells/cm2 for 
neuronal differentiation and maturation.
Primary antibodies 
The primary antibodies used are: rat anti-Bcl11b (Abcam,  ab18465, 1:500), mouse anti-
Coup-TF1 (Perseus Proteomics, PP-H8132-00, 1:200), custom rabbit anti-Dmrta2 (1:2000), 
custom guinea pig anti-Dmrta2 (1:2000), rabbit anti-Eomes (Abcam, ab23345, 1:500),
mouse anti-FORSE-1 (Developmental Studies Hybridoma Bank (DSHB,  1:500), goat anti-
FoxA2 (Santa Cruz, sc6554, 1:100), mouse anti-Gad65/67 (Merck Millipore,  Mab5406, 
1:500), mouse anti-GFP (Thermofisher Scientific,  A11120, 1:200), rabbit anti-Ki67 
(Novocastro, NCL-Ki67p, 1:500), mouse anti-Lim1 (DSHB, 1:10), custom guinea pig anti-
Lmx1a (1:1000), rabbit anti-Musashi1 (Merck Millipore,  AB5977, 1:200), chicken anti-Nestin 
(Neuromics, CH23001, 1:500), mouse anti-NeuN (Merck Millipore,  MAB377, 1:400), rabbit 
anti-Nkx2.1 (Abcam,  ab40880, 1:1000), rabbit anti-Nurr1 (Santa Cruz, sc990, 1:200), goat 
anti-Olig2 (R&D Systems, AF2418, 1:200), goat anti-Otx2 (Santa Cruz, sc30659, 1:100),
mouse anti-Pax6 (DSHB,  1:1000), rabbit anti-p27kip1 (Santa Cruz, sc528, 1:200), rabbit anti-
p57kip2 (Abcam,  ab4058, 1:250), mouse anti-SatB2 (Abcam,  ab51502, 1:10), rabbit anti-
Tbr1 (Abcam,  ab31940, 1:1000), sheep anti-Tyrosine Hydroxylase (Pel-Freez, P60101/1, 
1:500), rabbit anti-TUBB3 (Covance,  PRB-435p, 1:1000), rabbit anti-Tubb3 (Sigma, T2200, 
1:200) and mouse anti-vGlut1 (Merck Millipore, MAB5502, 1:500).
SI figure legends 
Fig. S1. ESC differentiation produces highly homogenous cultures of cortical NPCs and 
neurons. (A) Schematic representation of alternative differentiation protocols used to derive 
NPCs and neurons of ventral telencephalic, ventral midbrain and more caudal identities. (B) 
Additional characterisation data confirming Dmrta2 expression is restricted to telencephalic 
NPCs of dorsal, but not ventral, identity as demonstrated by co-localisation with Coup-TF1 
but not Nkx2.1. (C) Additional characterisation data demonstrating the absence of FoxA2 
staining in cortical NPC cultures. (D) Additional immunostaining data demonstrating the co-
localisation of Dmrta2 with Otx2 in cortical NPC cultures. (E-G) Additional characterisation 
data confirming a glutamatergic phenotype of neurons derived from cortical NPC cultures
demonstrated by positive immunostaining for Bcl11b and vGlut1, and an absence of staining 
for GAD65/67 (E), Th and Nurr1 (F), and Isl1 and Olig2 (G). All scale bars, 100 µm.
Fig. S2. Transgenic expression of Dmrta2 does not compromise NPC neurogenic 
competence. (A) Experimental scheme.  Monolayer cultures of Dmrta2-ESCs were exposed 
to doxycycline or vehicle control from day 5 to 9. Cultures were harvested at days 7, 9 and 
14 for qPCR and at day 14 for immunocytochemistry. (B) Phase contrast image of day 14 
cultures treated with vehicle or doxycycline between day 5-9, showing similar neuronal 
content. (C) Tubb3 antibody staining of day 14 sister cultures. (D) qPCR for Tubb3
demonstrating the recovery of Tubb3 expression levels at day 14 in doxycycline-treated 
cultures compared to control cultures.  
Fig. S3.  Generation and validation of Dmrta2flox/flox and Dmrta2-/- mESC lines. 
(A) The Dmrta2 gene was targeted by homologous recombination using a Dmrta2 targeting
construct containing 5’ and 3’ arms for homologous recombination. (B) Targeting was
screened by Southern Blots for 5’ and 3’ homologous recombination. ScaI digestion
generated a 8.1 kb fragment in wt and an 11.29 kb fragment in Dmrta2mut ESC cells detected
with 5’ probe. SacI digestion generated a 10.1 kb fragment in wt and an 8.88 kb fragment in
Dmrta2mut ES cells detected with 3’ probe (not shown). (C) Dmrta2flox alleles were
distinguished from wildtype Dmrta2 by PCR to generate 479bp and 365bp fragments,
respectively. (D) Corresponding images of Pax6 and Dmrta2 immunostaining of Dmrta2flox/flox
and Dmrta2-/- neural progenitor cells on day 8 of differentiation, confirming knockout of
Dmrta2 protein. Scale bar: 100 µm
Fig. S4.  Enforced expression of Dmrta2 transgene keeps cortical NPCs in the cell cycle. (A) 
Experimental scheme.  Monolayer cultures of Dmrta2-ESCs were exposed to doxycycline or 
vehicle control from day 5 to 12. Cultures were harvested every day from day 6 till 12 and 
samples processed for qPCR. (B) qPCR analysis of Cdkn1b and Cdkn1c from day 6-12. 
Levels of mRNA expression were normalised to day 5. Error bars indicate means ± s.e.m. of 
three biological replicates. (C) Day 12 cultures treated with doxycycline (middle) or vehicle 
(left) from day 5 were stained with antibodies against Ki67 (red) and counter stained with 
DAPI (blue), and quantification of Ki67+ cells. Scale bar: 100µm. 
Fig. S5.  Extended RNAseq data. (A, B) Top 10 enriched gene ontology terms for biological 
processes associated with transcripts identified as upregulated (A) or downregulated (B) in 
Dmrta2-/- NPCs relative to Dmrta2flox/flox NPCs. Differentially regulated transcripts used for this 
analysis were restricted to those with an adjusted p-value<0.01 and a fold change greater 
than two-fold. Modified Fisher’s exact p-value and Benjamini-Hochberg correction for 
multiple comparisons. (C) Top 15 transcripts identified as upregulated or downregulated in 
by Dmrta2-/- NPCs relative to Dmrta2flox/flox NPCs.
Supplementary table 1 – Primers used in PCR and qPCR
Gene F primer (5’3’) R primer (5’3’) Size (bp)
Dmrt5 genotyping - p1r GGACCTGCCCCCTAACAAGAGTA - -
Dmrt5 genotyping - p3f CGCGGCCTGCCTACGAAGTCTTTG - -
Dmrt5 genotyping - p4f GGGGTGGGGGCGTACTTGTTTACAG - -
Cyclophillin GGCAAATGCTGGACCAAACAC TTCCTGGACCCAAAACGCTC 147
Dmrt5 GCCTGCCTACGAAGTCTTTGGCTCGGTTT CGTCTTGGGAAACAGATCAAACTTCTGCAATTT 136
GAPDH AGGTCGGTGTGAACGGATTTG ACTGTGCCGTTGAATTTGCC 166
Hes1 TCGGTGGGTCCTAACGCAGT ACGGGTAGCAGTGGCCTGAG 105
HMBS ACTGGTGGAGTCTGGAGTCTAGATGGC GCCAGGCTGATGCCCAGGTT 181
Map2 CTGGACATCAGCCTCACTCA AATAGGTGCCCTGTGACCTG 163
Neurod1 CATGAGCGAGTCATGAGTGC GCACAGTGGATTCGTTTCCC 92
Neurod4 AGGCCAATGCTAGAGAACGG TCCTTGCCAGTCGAAGAGTC 129
Neurog2 GCTGTGGGAATTTCACCTGT AAATTTCCACGCTTGCATTC 236
Cdkn1b ACGCCAGACGTAAACAGCTC GAGGCAGATGGTTTAAGAGTGC 192
Cdkn1c GAGGAGCAGGACGAGAATCA CACGTTTGGAGAGGGACACC 198
Eomes GAGAAAGCGCCTGTCTCCCA CCCATGCCTTTGGAGGTGTC 108
Tubb3 ATCAGCAAGGTGCGTGAGGAG ATGGACAGGGTGGCGTTGTAG 113
ChIP - NBCR AGGACATCAGGTTCTGTGCC AGATTCCCCACAAGATTCCC 240
ChIP - Bs1 ACATACAGAGTTCGAGCGGG TTCTCTGGGCTTTGCTTAG 235
ChIP - Bs2 CGTGTCTCTTCCTCCCATTG ATTCCGCTGTTATCAGCACC 155
ChIP - Bs3 CCACCTCTCTCTTCTGACGG AGGCGCAATCCAATATGAAC 184





